{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:36:52Z","timestamp":1782283012006,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"None","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sebelipase alfa (Kanuma\u00ae) is approved for patients with Wolman disease (WD) at a dosage of 3\u20135\u00a0mg\/kg once weekly. Survival rates in the second of two clinical trials was greater, despite recruiting more severely ill patients, probably related to higher initial and maximal doses. We aimed to evaluate the effective pharmacokinetics and pharmacodynamics of Sebelipase alfa when administered to patients with severe WD at 5\u00a0mg\/kg twice weekly, an intensive regimen which was not assessed in the trials.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We recruited 3 patients receiving Sebelipase alfa 5\u00a0mg\/kg twice weekly. We measured LAL activity in leukocytes and plasma oxysterol concentration in two patients and LAL activity in fibroblasts in one patient. Clinical follow up was also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Analyses of LAL activity and oxysterols demonstrate that there is short-lived enzyme activity post-dosing which is associated with the release of stored lipids. Clinical data demonstrate that 5\u00a0mg\/kg twice weekly dosing is well tolerated and effective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>5\u00a0mg\/kg twice weekly dosing with Sebelipase alfa rescues severely ill infants with WD by increasing substrate clearance. There is biologically relevant lipid accumulation in the \u2018trough\u2019 periods before the next dosing, even with this intensive regimen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03219-5","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:02:55Z","timestamp":1719324175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Twice weekly dosing with Sebelipase alfa (Kanuma\u00ae) rescues severely ill infants with Wolman disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Mar\u00eda Jos\u00e9","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-0566","authenticated-orcid":false,"given":"Simon A","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"S\u00e1nchez-Pintos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L","family":"Couce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00f3bal","family":"Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Crujeiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Unceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Brammeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu Hoi","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"L\u00f3pez de Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Serrano-Gonzalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Camba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunabha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"2","key":"3219_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2019.11.004","volume":"129","author":"R Kohli","year":"2020","unstructured":"Kohli R, Ratziu V, Fiel MI, Waldmann E, Wilson DP, Balwani M. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group. Mol Genet Metab. 2020;129(2):59\u201366. https:\/\/doi.org\/10.1016\/j.ymgme.2019.11.004.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"3219_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3.3","volume":"2","author":"M Pericleous","year":"2017","unstructured":"Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Wolman\u2019s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017;2(9):670\u20139. https:\/\/doi.org\/10.1016\/S2468-1253(17)30052-3.3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"3219_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1161\/ATVBAHA.119.312136","volume":"39","author":"F Li","year":"2019","unstructured":"Li F, Zhang H. Lysosomal acid lipase in lipid metabolism and Beyond. Arterioscler Thromb Vasc Biol. 2019;39(5):850\u20136. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"3219_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MOL.0000000000000507","volume":"29","author":"H Zhang","year":"2018","unstructured":"Zhang H. Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies. Curr Opin Lipidol. 2018;29(3):218\u201323. https:\/\/doi.org\/10.1097\/MOL.0000000000000507.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"3219_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2018.09.028","volume":"70","author":"A Carter","year":"2019","unstructured":"Carter A, Brackley SM, Gao J, Mann JP. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD. J Hepatol. 2019;70(1):142\u201350. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.028.","journal-title":"J Hepatol"},{"issue":"4","key":"3219_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.aohep.2018.07.005","volume":"18","author":"A Consuelo-Sanchez","year":"2019","unstructured":"Consuelo-Sanchez A, V\u00e1zquez-Fr\u00edas R, Reyes-de la Rosa A, Acosta-Rodr\u00edguez-Bueno CP, Ortal-Vite MP, Cebolla JJ. Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency. Ann Hepatol. 2019;18(4):646\u201350. https:\/\/doi.org\/10.1016\/j.aohep.2018.07.005.","journal-title":"Ann Hepatol"},{"issue":"9","key":"3219_CR7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.medcli.2016.12.044","volume":"148","author":"C Camarena","year":"2017","unstructured":"Camarena C, Aldamiz-Echevarria LJ, Polo B, Barba Romero MA, Garc\u00eda I, Cebolla JJ, Ros E. Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management. Med Clin (Barc). 2017;148(9):429. .e1-429.e10.","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"3219_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1148\/radiographics.18.2.9536498","volume":"18","author":"AS Fulcher","year":"1998","unstructured":"Fulcher AS, Das Narla L, Hingsbergen EA. Pediatric case of the day. Wolman disease (primary familial xanthomatosis with involvement and clacification of the adrenal glands). Radiographics. 1998;18(2):533\u20135. https:\/\/doi.org\/10.1148\/radiographics.18.2.9536498.","journal-title":"Radiographics"},{"key":"3219_CR9","doi-asserted-by":"publisher","first-page":"100833","DOI":"10.1016\/j.ymgmr.2021.100833","volume":"30","author":"F Baronio","year":"2021","unstructured":"Baronio F, Conti F, Miniaci A, Carfagnini F, Di Natale V, Di Donato G, Testi M, Totaro C, De Fanti A, Boenzi S, Dionisi-Vici C, Esposito S, Pession A. Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis. Mol Genet Metab Rep. 2021;30:100833. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100833.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"3219_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12288-020-01350-4","volume":"37","author":"S Bartakke","year":"2021","unstructured":"Bartakke S, Nisal A, Bafna V, Valecha A. Secondary Hemophagocytic Lymphohistiocytosis in an infant with Wolman Disease. Indian J Hematol Blood Transfus. 2021;37(1):191\u20132. https:\/\/doi.org\/10.1007\/s12288-020-01350-4.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"3219_CR11","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1097\/MPH.0000000000001192","volume":"41","author":"F Tinsa","year":"2019","unstructured":"Tinsa F, Ben Romdhane M, Boudabous H, Bel Hadj I, Brini I, Tebib N, Louati H, Bekri S, Boussetta K. A Novel Mutation c.153 C\u2009>\u2009A in a Tunisian girl with Wolman Disease and unusual presentation: Hemophagocytic Lymphohistiocytosis. J Pediatr Hematol Oncol. 2019;41(3):e193\u20136. https:\/\/doi.org\/10.1097\/MPH.0000000000001192.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"3219_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/gim.2015.108","volume":"18","author":"SA Jones","year":"2016","unstructured":"Jones SA, Valayannopoulos V, Schneider E, Eckert S, Banikazemi M, Bialer M, Cederbaum S, Chan A, Dhawan A, Di Rocco M, Domm J, Enns GM, Finegold D, Gargus JJ, Guardamagna O, Hendriksz C, Mahmoud IG, Raiman J, Selim LA, Whitley CB, Zaki O, Quinn AG. Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants. Genet Med. 2016;18(5):452\u20138. https:\/\/doi.org\/10.1038\/gim.2015.108.","journal-title":"Genet Med"},{"issue":"15\u201316","key":"3219_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","volume":"413","author":"J Hamilton","year":"2012","unstructured":"Hamilton J, Jones I, Srivastava R, Galloway P. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor lalistat 2. Clin Chim Acta. 2012;413(15\u201316):1207\u201310. https:\/\/doi.org\/10.1016\/j.cca.2012.03.019.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"3219_CR14","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/humu.23837","volume":"40","author":"G Del Angel","year":"2019","unstructured":"Del Angel G, Hutchinson AT, Jain NK, Forbes CD, Reynders J. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency. Hum Mutat. 2019;40(11):2007\u201320. https:\/\/doi.org\/10.1002\/humu.23837.","journal-title":"Hum Mutat"},{"issue":"1","key":"3219_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s13023-021-02134-3","volume":"16","author":"T Demaret","year":"2021","unstructured":"Demaret T, Lacaille F, Wicker C, Arnoux JB, Bouchereau J, Belloche C, Gitiaux C, Grevent D, Broissand C, Adjaoud D, Abi Warde MT, Plantaz D, Bekri S, de Lonlay P, Brassier A. Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up. Orphanet J Rare Dis. 2021;16(1):507. https:\/\/doi.org\/10.1186\/s13023-021-02134-3.","journal-title":"Orphanet J Rare Dis"},{"key":"3219_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jhep.2021.10.026","volume":"76","author":"BK Burton","year":"2022","unstructured":"Burton BK, Feillet F, Furuya KN, Marulkar S, Balwani M. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: final results of the ARISE study. J Hepatol. 2022;76:577\u201387. https:\/\/doi.org\/10.1016\/j.jhep.2021.10.026.","journal-title":"J Hepatol"},{"issue":"3","key":"3219_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/hep.26289","volume":"58","author":"M Balwani","year":"2013","unstructured":"Balwani M, Breen C, Enns GM, Deegan PB, Honz\u00edk T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schneider E, Quinn AG. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology. 2013;58(3):950\u20137. https:\/\/doi.org\/10.1002\/hep.26289.","journal-title":"Hepatology"},{"issue":"6","key":"3219_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/MPG.0000000000003452","volume":"74","author":"BK Burton","year":"2022","unstructured":"Burton BK, Sanchez AC, Kostyleva M, Martins AM, Marulkar S, Abel F, Bari\u0107 I. Long-term sebelipase Alfa Treatment in children and adults with lysosomal Acid Lipase Deficiency. J Pediatr Gastroenterol Nutr. 2022;74(6):757\u201364. https:\/\/doi.org\/10.1097\/MPG.0000000000003452.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"3219_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-017-0587-3","volume":"12","author":"SA Jones","year":"2017","unstructured":"Jones SA, Rojas-Caro S, Quinn AG, Friedman M, Marulkar S, Ezgu F, Zaki O, Gargus JJ, Hughes J, Plantaz D, Vara R, Eckert S, Arnoux JB, Brassier A, Le Quan Sang KH, Valayannopoulos V. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Orphanet J Rare Dis. 2017;12(1):25. https:\/\/doi.org\/10.1186\/s13023-017-0587-3.","journal-title":"Orphanet J Rare Dis"},{"key":"3219_CR20","doi-asserted-by":"publisher","unstructured":"Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F, Marulkar S, Jones SA. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet J Rare Dis. 2021;16(1):13. https:\/\/doi.org\/10.1186\/s13023-020-01577-4. Erratum in: Orphanet J Rare Dis. 2021;16(1):113. PMID: 33407676; PMCID: PMC7789691.","DOI":"10.1186\/s13023-020-01577-4"},{"issue":"3","key":"3219_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0009-8981(78)90253-x","volume":"84","author":"GJ Guy","year":"1978","unstructured":"Guy GJ, Butterworth J. Acid esterase activity in cultured skin fibroblasts and amniotic fluid cells using 4-methylumbelliferyl palmitate. Clin Chim Acta. 1978;84(3):361\u201371. https:\/\/doi.org\/10.1016\/0009-8981(78)90253-x.","journal-title":"Clin Chim Acta"},{"key":"3219_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cca.2017.05.027","volume":"471","author":"Z Lukacs","year":"2017","unstructured":"Lukacs Z, Barr M, Hamilton J. Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor lalistat 2. Clin Chim Acta. 2017;471:201\u20135. https:\/\/doi.org\/10.1016\/j.cca.2017.05.027. Epub 2017 May 19. PMID: 28532785.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"3219_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1194\/jlr.D044024","volume":"55","author":"N Lin","year":"2014","unstructured":"Lin N, Zhang H, Qiu W, Ye J, Han L, Wang Y, Gu X. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-pick disease. J Lipid Res. 2014;55(2):338\u201343. https:\/\/doi.org\/10.1194\/jlr.D044024.","journal-title":"J Lipid Res"},{"issue":"4","key":"3219_CR24","doi-asserted-by":"publisher","first-page":"e0123771","DOI":"10.1371\/journal.pone.0123771","volume":"10","author":"R Narayanaswamy","year":"2015","unstructured":"Narayanaswamy R, Iyer V, Khare P, Bodziak ML, Badgett D, Zivadinov R, Weinstock-Guttman B, Rideout TC, Ramanathan M, Browne RW. Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS. PLoS ONE. 2015;10(4):e0123771. https:\/\/doi.org\/10.1371\/journal.pone.0123771.","journal-title":"PLoS ONE"},{"issue":"1","key":"3219_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ymgme.2020.02.008","volume":"130","author":"JA Cooper","year":"2020","unstructured":"Cooper JA, Church HJ, Wu HY, Cholestane-3\u03b2. 5\u03b1, 6\u03b2-triol: further insights into the performance of this oxysterol in diagnosis of Niemann-pick disease type C. Mol Genet Metab. 2020;130(1):77\u201386. https:\/\/doi.org\/10.1016\/j.ymgme.2020.02.008.","journal-title":"Mol Genet Metab"},{"key":"3219_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/8904_2017_6","volume":"37","author":"C Ruiz-Andr\u00e9s","year":"2017","unstructured":"Ruiz-Andr\u00e9s C, Sell\u00e9s E, Arias A, Gort L, Spanish LAL, Deficiency Working Group. Lysosomal Acid Lipase Deficiency in 23 Spanish patients: high frequency of the Novel c.966\u2009+\u20092T\u2009>\u2009G mutation in Wolman Disease. JIMD Rep. 2017;37:7\u201312. https:\/\/doi.org\/10.1007\/8904_2017_6.","journal-title":"JIMD Rep"},{"issue":"1","key":"3219_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13023-021-01849-7","volume":"16","author":"JE Potter","year":"2021","unstructured":"Potter JE, Petts G, Ghosh A, White FJ, Kinsella JL, Hughes S, Roberts J, Hodgkinson A, Brammeier K, Church H, Merrigan C, Hughes J, Evans P, Campbell H, Bonney D, Newman WG, Bigger BW, Broomfield A, Jones SA, Wynn RF. Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease. Orphanet J Rare Dis. 2021;16(1):235. https:\/\/doi.org\/10.1186\/s13023-021-01849-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3219_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.prp.2003.11.001","volume":"200","author":"R Boldrini","year":"2004","unstructured":"Boldrini R, Devito R, Biselli R, Filocamo M, Bosman C. Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy. Pathol Res Pract. 2004;200(3):231\u201340. https:\/\/doi.org\/10.1016\/j.prp.2003.11.001.","journal-title":"Pathol Res Pract"},{"key":"3219_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/DDDT.S149264","volume":"14","author":"GM Pastores","year":"2020","unstructured":"Pastores GM, Hughes DA. Lysosomal Acid Lipase Deficiency: Therapeutic options. Drug Des Devel Ther. 2020;14:591\u2013601. https:\/\/doi.org\/10.2147\/DDDT.S149264.","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"3219_CR30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/hmg\/7.9.1347","volume":"7","author":"H Du","year":"1998","unstructured":"Du H, Duanmu M, Witte D, Grabowski GA. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage. Hum Mol Genet. 1998;7(9):1347\u201354. https:\/\/doi.org\/10.1093\/hmg\/7.9.1347.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3219_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0022-2275(20)31157-3","volume":"42","author":"H Du","year":"2001","unstructured":"Du H, Heur M, Duanmu M, Grabowski GA, Hui DY, Witte DP, Mishra J. Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J Lipid Res. 2001;42(4):489\u2013500.","journal-title":"J Lipid Res"},{"issue":"3","key":"3219_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymgme.2014.04.006","volume":"112","author":"Y Sun","year":"2014","unstructured":"Sun Y, Xu YH, Du H, Quinn B, Liou B, Stanton L, Inskeep V, Ran H, Jakubowitz P, Grilliot N, Grabowski GA. Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency disease. Mol Genet Metab. 2014;112(3):229\u201341. https:\/\/doi.org\/10.1016\/j.ymgme.2014.04.006.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"3219_CR33","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1194\/jlr.M700482-JLR200","volume":"49","author":"H Du","year":"2008","unstructured":"Du H, Cameron TL, Garger SJ, Pogue GP, Hamm LA, White E, Hanley KM, Grabowski GA. Wolman disease\/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J Lipid Res. 2008;49(8):1646\u201357. https:\/\/doi.org\/10.1194\/jlr.M700482-JLR200.","journal-title":"J Lipid Res"},{"issue":"16","key":"3219_CR34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","volume":"10","author":"H Du","year":"2001","unstructured":"Du H, Schiavi S, Levine M, Mishra J, Heur M, Grabowski GA. Enzyme therapy for lysosomal acid lipase deficiency in the mouse. Hum Mol Genet. 2001;10(16):1639\u201348. https:\/\/doi.org\/10.1093\/hmg\/10.16.1639.","journal-title":"Hum Mol Genet"},{"key":"3219_CR35","doi-asserted-by":"crossref","unstructured":"Du H, Levine M, Ganesa C, Witte DP, Cole ES, Grabowski GA. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. Am J Hum Genet. 2005;77(6):1061-74. doi: 10.1086\/498652. 36 Hollak, C.E.M. Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders. Orphanet J Rare Dis. 2011;6:16. doi: 10.1186\/1750-1172-6-16","DOI":"10.1186\/1750-1172-6-16"},{"key":"3219_CR36","doi-asserted-by":"publisher","unstructured":"Hollak CEM, Sirrs S, van den Berg S, van der Wel V, Langeveld M, Dekker H, Lachmann R, de Visser SJ. Registries for orphan drugs: generating evidence or marketing tools? Orphanet J Rare Dis. 2020;15(1):235. https:\/\/doi.org\/10.1186\/s13023-020-01519-0.","DOI":"10.1186\/s13023-020-01519-0"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03219-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:06:09Z","timestamp":1719324369000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03219-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3219"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03219-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the parents to participate and to submit and publish the results in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mar\u00eda Jos\u00e9 de Castro, Simon A Jones, Javier de las Heras, Cristobal Col\u00f3n and Fiona J White have received honoraria and consultancy fees from Alexion. The remaining authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}